Aspira Pathlab & Diagnostics Ltd — Updates, 17-05-2025: Company Update

Aspira Pathlab & Diagnostics Limited has announced a board meeting to consider the financial results for the quarter and half-year ended March 31, 2025. The company reported standalone and consolidated revenues of ₹577.67 lakh and ₹577.67 lakh respectively for the quarter, with net profits after tax of ₹72.33 lakh (standalone) and ₹68.06 lakh (consolidated). For the year, consolidated revenue was ₹2,199.90 lakh with a net profit after tax of ₹202.26 lakh. Earnings per share stood at ₹0.70 (basic, standalone) and ₹0.66 (basic, consolidated) for the quarter. The results reflect a return to profitability compared to losses in the previous year, signaling operational improvement.